Comparisons
NAD+, MOTS-c and 5-Amino-1MQ: Three Different Levers
A cofactor, a mitochondrially encoded peptide and an enzyme inhibitor. Why no co-administration literature exists and what a blend arm can show.
Comparisons
A cofactor, a mitochondrially encoded peptide and an enzyme inhibitor. Why no co-administration literature exists and what a blend arm can show.
Research Reviews
5-Amino-1MQ is a permanently charged quinolinium cation that inhibits NNMT. Why the charge, the salt form and the CAS number all matter.
Comparisons
One blocks an enzyme that consumes nicotinamide; the other is the cofactor itself. Adjacent chemistry, opposite interventions, different controls.
Comparisons
One is a small-molecule enzyme inhibitor, the other a growth hormone fragment. Different classes, different handling, different kinds of evidence.
Research Reviews
Searches for 5-Amino-1MQ human trials return nothing in PubMed. The evidence is preclinical NNMT inhibition, and the gaps are worth naming.
Comparisons
Three metabolic research compounds with three different mechanisms: a nuclear receptor agonist, a mitochondrial peptide and an enzyme inhibitor.
Lab Handling
5-Amino-1MQ is a quaternary ammonium cation supplied as a salt. Why the counterion is named on the label, and what its purity data should show.
Peptide Profiles
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase, studied as a way to probe NAD salvage and NNMT biology in cell and rodent work.